Decoding ADGRE5: How Proteolytic Cleavage and Mechanical Forces Unleash Cellular Signals
The adhesion G protein-coupled receptor ADGRE5/CD97 is upregulated in many cancers, representing a potential drug target in oncology/immuno-oncology. Yet, ADGRE5's activation and signaling mechanisms remain poorly understood. Here, we used enhanced bystander bioluminescence resonance energy transfer (ebBRET)-based biosensors and three strategies to characterize human (h) ADGRE5 signaling. First, a synthetic tobacco etch virus (TEV) protease-cleavable receptor chimera enabling controlled tethered agonist (TA) exposure at the GPCR proteolysis site (GPS) revealed signaling through Gα12 and Gα13, along with the recruitment of β-Arrestins 1/2 (β-Arrs). Second, we investigated WT hADGRE5 signaling elicited by Gingipain K (Kgp), an endopeptidase that cleaves hADGRE5 upstream of the GAIN domain. Kgp mirrored TEV-induced signaling but also promoted Gαz and Gα11 activity. The abolition of hADGRE5's GPS did not block Kgp-induced receptor activation, revealing a GPS cleavage-independent mechanism of action. Finally, we developed an assay to study hADGRE5 mechanical stimulation (MS) using β-Arr2 as a readout. MS promoted β-Arr2 recruitment in hADGRE5-expressing cells, and this response was lost upon abolition of the GPS. A neutralizing antibody to the hADGRE5 ligand CD55 significantly dampened MS-induced β-Arr2 engagement. Overall, this study advances our understanding of hADGRE5's signaling and highlights the receptor's plasticity in activating pathways via both GPS cleavage-dependent and -independent mechanisms.
Authors
- Laurent Sabbagh (ORCID: https://orcid.org/0000-0002-5097-4298)
- Ana L. Moreno-Salinas (ORCID: https://orcid.org/0000-0003-1866-9290)
- Herthana Kandasamy
- Arturo Mancini
- Sandra Morissette
- Richard Leduc (ORCID: https://orcid.org/0000-0001-6854-8003)
- Michel Bouvier (ORCID: https://orcid.org/0000-0003-1128-0100)
- Samya Aouad (ORCID: https://orcid.org/0009-0009-1563-8270)
- Arhamatoulaye Maïga
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Université de Sherbrooke (CA)
- Institute for Research in Immunology and Cancer (CA)
- Domain Therapeutics (France) (FR)
Publication Details
- Journal
- Cells
- Published
- 2025-08-19
- DOI
- https://doi.org/10.3390/cells14161284
- Citations
- 1
- Primary Topic
- Receptor Mechanisms and Signaling
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- Mitacs
- Canadian Institutes of Health Research